A detailed history of Taylor Frigon Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Taylor Frigon Capital Management LLC holds 160,046 shares of NVCR stock, worth $4.93 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
160,046
Previous 133,298 20.07%
Holding current value
$4.93 Million
Previous $2.28 Million 9.55%
% of portfolio
1.26%
Previous 1.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$15.61 - $23.34 $417,536 - $624,298
26,748 Added 20.07%
160,046 $2.5 Million
Q2 2024

Jul 29, 2024

BUY
$11.83 - $24.05 $75,522 - $153,535
6,384 Added 5.03%
133,298 $2.28 Million
Q1 2024

Apr 19, 2024

BUY
$12.42 - $17.29 $373,307 - $519,685
30,057 Added 31.03%
126,914 $1.98 Million
Q4 2023

Jan 29, 2024

BUY
$11.13 - $15.78 $60,346 - $85,559
5,422 Added 5.93%
96,857 $1.45 Million
Q3 2023

Oct 25, 2023

BUY
$16.15 - $42.35 $400,358 - $1.05 Million
24,790 Added 37.2%
91,435 $1.48 Million
Q2 2023

Jul 28, 2023

BUY
$40.29 - $82.51 $1.02 Million - $2.08 Million
25,244 Added 60.97%
66,645 $2.77 Million
Q1 2023

Apr 25, 2023

SELL
$56.44 - $118.81 $37,250 - $78,414
-660 Reduced 1.57%
41,401 $2.49 Million
Q4 2022

Feb 03, 2023

SELL
$63.98 - $85.37 $182,790 - $243,902
-2,857 Reduced 6.36%
42,061 $3.09 Million
Q3 2022

Nov 04, 2022

SELL
$67.99 - $89.57 $1.63 Million - $2.15 Million
-23,990 Reduced 34.81%
44,918 $3.41 Million
Q2 2022

Aug 04, 2022

SELL
$56.6 - $89.9 $232,399 - $369,129
-4,106 Reduced 5.62%
68,908 $4.79 Million
Q1 2022

Apr 25, 2022

BUY
$60.15 - $84.52 $1.6 Million - $2.25 Million
26,638 Added 57.44%
73,014 $6.05 Million
Q4 2021

Jan 21, 2022

BUY
$75.08 - $121.99 $39,642 - $64,410
528 Added 1.15%
46,376 $3.48 Million
Q3 2021

Oct 27, 2021

BUY
$116.17 - $194.55 $1.72 Million - $2.88 Million
14,813 Added 47.73%
45,848 $5.33 Million
Q2 2021

Jul 26, 2021

SELL
$130.4 - $225.58 $2.3 Million - $3.97 Million
-17,614 Reduced 36.21%
31,035 $6.88 Million
Q1 2021

Apr 23, 2021

SELL
$124.11 - $190.17 $42,321 - $64,847
-341 Reduced 0.7%
48,649 $6.43 Million
Q4 2020

Jan 22, 2021

BUY
$112.16 - $174.14 $234,863 - $364,649
2,094 Added 4.47%
48,990 $8.48 Million
Q3 2020

Oct 20, 2020

BUY
$58.05 - $111.31 $34,365 - $65,895
592 Added 1.28%
46,896 $5.22 Million
Q2 2020

Jul 22, 2020

BUY
$57.2 - $74.41 $194,594 - $253,142
3,402 Added 7.93%
46,304 $2.75 Million
Q1 2020

May 06, 2020

BUY
$57.05 - $95.75 $400,719 - $672,548
7,024 Added 19.58%
42,902 $2.89 Million
Q1 2020

Apr 24, 2020

SELL
$57.05 - $95.75 $125,224 - $210,171
-2,195 Reduced 5.77%
35,878 $2.42 Million
Q4 2019

Jan 24, 2020

SELL
$68.3 - $93.8 $213,437 - $293,125
-3,125 Reduced 7.59%
38,073 $3.21 Million
Q3 2019

Nov 01, 2019

SELL
$61.86 - $97.8 $334,105 - $528,217
-5,401 Reduced 11.59%
41,198 $3.08 Million
Q2 2019

Jul 17, 2019

BUY
$42.22 - $63.23 $173,524 - $259,875
4,110 Added 9.67%
46,599 $2.95 Million
Q1 2019

Apr 25, 2019

SELL
$31.96 - $56.12 $38,256 - $67,175
-1,197 Reduced 2.74%
42,489 $2.05 Million
Q4 2018

Feb 07, 2019

BUY
$28.72 - $52.63 $1.25 Million - $2.3 Million
43,686 New
43,686 $1.46 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Taylor Frigon Capital Management LLC Portfolio

Follow Taylor Frigon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.